Studying non-alcoholic fatty liver disease with zebrafish: A confluence of optics, genetics, and physiology

Cellular and Molecular Life Sciences

Volumn 69, Issue 23, 2012, Pages 3953-3961

  Schlegel, Amnon ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatic steatosis; Lipid metabolism; Non alcoholic fatty liver disease; Zebrafish

Indexed keywords

ADENOSYLHOMOCYSTEINASE; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTIDINE DIPHOSPHATE DIACYLGLYCEROL INOSITOL 3 PHOSPHATIDYLTRANSFERASE; MONOCARBOXYLATE TRANSPORTER; PROTEIN KINASE LKB1; SOLUTE CARRIER FAMILY 16 MEMBER 6A; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CHOLESTEROL DIET; DISEASE ASSOCIATION; DISEASE MODEL; GENE EXPRESSION; GENETIC SCREENING; HYPERTRIGLYCERIDEMIA; INTESTINE FLORA; LIPID METABOLISM; LIPID TRANSPORT; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; PHENOTYPE; REVIEW; ZEBRA FISH; ANIMAL; GASTROINTESTINAL TRACT; GENETICS; HUMAN; LIVER CELL; METABOLISM; MICROBIOLOGY; MICROFLORA; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY;

DANIO RERIO; VERTEBRATA;

ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; HEPATOCYTES; HUMANS; MICROBIOTA; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ZEBRAFISH;

EID: 84869096869     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1037-y     Document Type: Review

References (65)

1. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS (2005) A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352:1138-1145
2. Stewart ST, Cutler DM, Rosen AB (2009) Forecasting the effects of obesity and smoking on US life expectancy. N Engl J Med 361:2252-2260
3. Rosen ED, MacDougald OA (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7:885-896
4. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625-1638
5. Clark JM (2006) The epidemiology of non-alcoholic fatty liver disease in adults. J Clin Gastroenterol 40:S5-S10
6. Gastaldelli A, Kozakova M, Højlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Beverley B, Investigators TR (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537-1544
7. Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332:1519-1523
8. Hooper AJ, Adams LA, Burnett JR (2011) Genetic determinants of hepatic steatosis in man. J Lipid Res 52:593-617
9. Huang Y, Cohen JC, Hobbs HH (2011) Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J Biol Chem 286:37085-37093
10. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40:1461-1465
11. Chen W, Chang B, Li L, Chan L (2010) Patatin-like phospholipase domain-containing 3/Adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 52:1134-1142
12. Basantani MK, Sitnick MT, Cai L, Brenner DS, Gardner NP, Li JZ, Schoiswohl G, Yang K, Kumari M, Gross RW, Zechner R, Kershaw EE (2011) Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 52:318-329
13. He S, McPhaul C, Li JZ, Garuti R, Kinch L, Grishin NV, Cohen JC, Hobbs HH (2010) A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 285:6706-6715
14. Kumari M, Schoiswohl G, Chitraju C, Paar M, Cornaciu I, Rangrez Ashraf Y, Wongsiriroj N, Nagy Harald M, Ivanova Pavlina T, Scott Sarah A, Knittelfelder O, Rechberger Gerald N, Birner-Gruenberger R, Eder S, Brown HA, Haemmerle G, Oberer M, Lass A, Kershaw Erin E, Zimmermann R, Zechner R (2012) Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab 15:691-702
15. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, Nalls MA, Clark JM, Mitchell BD, Shuldiner AR, Butler JL, Tomas M, Hoffmann U, Hwang S-J, Massaro JM, O'Donnell CJ, Sahani DV, Salomaa V, Schadt EE, Schwartz SM, Siscovick DS, Voight BF, Carr JJ, Feitosa MF, Harris TB, Fox CS, Smith AV, Kao WHL, Hirschhorn JN, Borecki IB, Nash CRN, Consortium G, Investigators M, Consortium G (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 7:e1001324
16. Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang X-M, Dziura J, Lifton RP, Shulman GI (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. New Engl J Med 362:1082-1089
17. Liou I, Kowdley KV (2006) Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol 40:S11-S16
18. Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K (2006) A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355:2297-2307
19. Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362:1675-1685
20. Nugent C, Younossi ZM (2007) Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 4:432-441
21. Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147-152
22. Patton EE, Zon LI (2001) The art and design of genetic screens: zebrafish. Nat Rev Genet 2:956-966
23. Lieschke GJ, Currie PD (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8:353-367
24. Schlegel A, Stainier DYR (2007) Lessons from lower organisms: what worms, flies, and zebrafish can teach us about human energy metabolism. PLoS Genet 3:e199
25. Babin PJ, Thisse C, Durliat M, Andre M, Akimenko MA, Thisse B (1997) Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development. Proc Natl Acad Sci USA 94:8622-8627
26. Babin PJ, Vernier JM (1989) Plasma lipoproteins in fish. J Lipid Res 30:467-489
27. Marza E, Barthe C, Andre M, Villeneuve L, Helou C, Babin PJ (2005) Developmental expression and nutritional regulation of a zebrafish gene homologous to mammalian microsomal triglyceride transfer protein large subunit. Dev Dyn 232:506-518
28. Schlegel A, Stainier DY (2006) Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae. Biochemistry 45:15179-15187
29. Yin W, Carballo-Jane E, McLaren DG, Mendoza VH, Gagen K, Geoghagen NS, McNamara LA, Gorski JN, Eiermann GJ, Petrov A, Wolff M, Tong X, Wilsie LC, Akiyama TE, Chen J, Thankappan A, Xue J, Ping X, Andrews G, Wickham LA, Gai CL, Trinh T, Kulick AA, Donnelly MJ, Voronin GO, Rosa R, Cumiskey A-M, Bekkari K, Mitnaul LJ, Puig O, Chen F, Raubertas R, Wong PH, Hansen BC, Koblan KS, Roddy TP, Hubbard BK, Strack AM (2012) Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res 53:51-65
30. Stoletov K, Fang L, Choi S-H, Hartvigsen K, Hansen LF, Hall C, Pattison J, Juliano J, Miller ER, Almazan F, Crosier P, Witztum JL, Klemke RL, Miller YI (2009) Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ Res 104:952-960
31. Fang L, Green SR, Baek JS, Lee S-H, Ellett F, Deer E, Lieschke GJ, Witztum JL, Tsimikas S, Miller YI (2011) In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish. J Clin Invest 121:4861-4869
32. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. New Engl J Med 363:1341-1350
33. Oka T, Nishimura Y, Zang L, Hirano M, Shimada Y, Wang Z, Umemoto N, Kuroyanagi J, Nishimura N, Tanaka T (2010) Dietinduced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol 10:21
34. Pardo-Martin C, Chang T-Y, Koo BK, Gilleland CL, Wasserman SC, Yanik MF (2010) High-throughput in vivo vertebrate screening. Nat Methods 7:634-636
35. Tainaka T, Shimada Y, Kuroyanagi J, Zang L, Oka T, Nishimura Y, Nishimura N, Tanaka T (2011) Transcriptome analysis of antifatty liver action by Campari tomato using a zebrafish dietinduced obesity model. Nutr Metab 8:88
36. Sukardi H, Zhang X, Lui EY, Ung CY, Mathavan S, Gong Z, Lam SH (2012) Liver X receptor agonist T0901317 induced liver perturbation in zebrafish: histological, gene set enrichment and expression analyses. Biochim Biophys Acta 1820:33-43
37. Oosterveer MH, Grefhorst A, Groen AK, Kuipers F (2010) The liver X receptor: control of cellular lipid homeostasis and beyond implications for drug design. Prog Lipid Res 49:343-352
38. Matthews RP, Lorent K, Manoral-Mobias R, Huang Y, Gong W, Murray IVJ, Blair IA, Pack M (2009) TNF-a-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase. Development 136:865-875
39. Sadler KC, Amsterdam A, Soroka C, Boyer J, Hopkins N (2005) A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. Development 132:3561-3572
40. Thakur PC, Stuckenholz C, Rivera MR, Davison JM, Yao JK, Amsterdam A, Sadler KC, Bahary N (2011) Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish. Hepatology 54:452-462
41. Hugo SE, Cruz-Garcia L, Karanth S, Anderson RM, Stainier DYR, Schlegel A (2012) A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev 26:282-293
42. van der Velden YU, Wang L, Zevenhoven J, van Rooijen E, van Lohuizen M, Giles RH, Clevers H, Haramis A-PG (2011) The serine-threonine kinase LKB1 is essential for survival under energetic stress in zebrafish. Proc Natl Acad Sci USA 108:4358-4363
43. Scrivens PJ, Noueihed B, Shahrzad N, Hul S, Brunet S, Sacher M (2011) C4orf41 and TTC-15 are mammalian TRAPP components with a role at an early stage in ER-to-Golgi trafficking. Mol Biol Cell 22:2083-2093
44. Wendler F, Gillingham AK, Sinka R, Rosa-Ferreira C, Gordon DE, Franch-Marro X, Peden AA, Vincent J-P, Munro S (2010) A genome-wide RNA interference screen identifies two novel components of the metazoan secretory pathway. EMBO J 29:304-314
45. Cinaroglu A, Gao C, Imrie D, Sadler KC (2011) Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish. Hepatology 54:495-508
46. Yee NS, Lorent K, Pack M (2005) Exocrine pancreas development in zebrafish. Dev Biol 284:84-101
47. Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081-1086
48. Veech RL (2004) The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70:309-319
49. Anderson RM, Bosch JA, Goll M, Hesselson D, Duc PD, Shin D, Chi NA, Shin C, Schlegel A, Halpern M, Stainier DYR (2009) Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration. Dev Biol 334:213-223
50. Guryev V, Koudijs MJ, Berezikov E, Johnson SL, Plasterk RHA, van Eeden FJM, Cuppen E (2006) Genetic variation in the zebrafish. Genome Res 16:491-497
51. Wienholds E, van Eeden F, Kosters M, Mudde J, Plasterk RHA, Cuppen E (2003) Efficient target-selected mutagenesis in zebrafish. Genome Res 13:2700-2707
52. Jansen M, ten Klooster JP, Offerhaus GJ, Clevers H (2009) LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol Rev 89:777-798
53. Shaw RJ, Lamia KA, Vasquez D, Koo S-H, Bardeesy N, DePinho RA, Montminy M, Cantley LC (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642-1646
54. Brown KH, Dobrinski KP, Lee AS, Gokcumen O, Mills RE, Shi X, Chong WWS, Chen JYH, Yoo P, David S, Peterson SM, Raj T, Choy KW, Stranger BE, Williamson RE, Zon LI, Freeman JL, Lee C (2012) Extensive genetic diversity and substructuring among zebrafish strains revealed through copy number variant analysis. Proc Natl Acad Sci USA 109:529-534
55. Carten JD, Bradford MK, Farber S (2011) Visualizing digestive organ morphology and function using differential fatty acid metabolism in live zebrafish. Dev Biol 360:276-285
56. Sakaguchi TF, Sadler KC, Crosnier C, Stainier DYR (2008) Endothelial signals modulate hepatocyte apicobasal polarization in zebrafish. Curr Biol 18:1565-1571
57. Zhan Y-T, An W (2010) Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 16:4652-4660
58. Wittamer V, Bertrand JY, Gutschow PW, Traver D (2011) Characterization of the mononuclear phagocyte system in zebrafish. Blood 117:7126-7135
59. De Minicis S, Svegliati-Baroni G (2011) Fibrogenesis in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 5:179-187
60. Yin C, Evason KJ, Maher JJ, Stainier DYR (2012) The bHLH transcription factor Hand2 marks hepatic stellate cells in zebrafish: analysis of stellate cell entry into the developing liver. Hepatology (in press)
61. Flynn EJ III, Trent CM, Rawls JF (2009) Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio). J Lipid Res 50:1641-1652
62. Imrie D, Sadler KC (2010) White adipose tissue development in zebrafish is regulated by both developmental time and fish size. Dev Dyn 239:3013-3023
63. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI (2011) Human nutrition, the gut microbiome and the immune system. Nature 474:327-336
64. Szabo G, Bala S, Petrasek J, Gattu A (2010) Gut-liver axis and sensing microbes. Dig Dis 28:737-744
65. Roeselers G, Mittge EK, Stephens WZ, Parichy DM, Cavanaugh CM, Guillemin K, Rawls JF (2011) Evidence for a core gut microbiota in the zebrafish. ISME J 5:1595-1608